Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NASDAQ:AMRX   2:12:47 PM EDT
6.15
+0.02 (+0.41%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.90B
Current PEN/A
Forward PE 10.59
2yr Forward PE 9.3
See more stats
Estimates Current Quarter
Revenue$618.09 Million
Adjusted EPS$0.09
See more estimates
10-Day MA$5.96
50-Day MA$5.63
200-Day MA$4.48
See more pivots

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Stock, NASDAQ:AMRX

400 Crossing Boulevard, 3rd floor, Bridgewater, New Jersey 08807
Phone: +1.908.947.3120
Number of Employees: 7850

Description

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.